期刊文献+

今又生联合化疗治疗恶性胸腔积液的护理体会 被引量:4

下载PDF
导出
摘要 目的探讨今又生联合化疗治疗恶性胸腔积液的护理体会。方法12例经病理组织学或细胞学确诊的恶性间皮瘤、肺癌伴恶性胸膜腔积液的患者,胸腔置引流管排出积液后,用100ml生理盐水溶解重组人腺病毒p53注射液(今又生)1支(1×1012VP)经引流管注入胸腔,1次/周,共注射2~4次,同时胸腔一次性注入顺铂60mg,治疗4周后评价积液控制效果。对本组患者术前、术后进行整体护理及分析。结果对所有患者术前、术中及术后进行较合理的护理,12例患者均顺利完成治疗。结论正确合理的护理是今又生联合化疗治疗恶性胸腔积液的一个重要环节。
作者 李岩 马海英
出处 《中国现代药物应用》 2007年第10期61-,共1页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献3

  • 1[1]Swisher SG,Roth JA,Komaki R,et al.Introduction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.Clin Cancer Res.2003,9 (1):93-101.
  • 2[2]D'Orazi G,Marchetti A,Crescenzi M,et al.Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts:implications for cancer gene therapy without tumor targeting.J Gene Med,2000,2(1):11-21.
  • 3彭朝晖,张晓志.国外重组腺病毒-p53制品对肿瘤基因治疗临床研究的概况[J].中华医学杂志,2003,83(23):2098-2100. 被引量:37

二级参考文献25

  • 1Clayman GL, el-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol, 1998, 16:2221-2232.
  • 2Swisher SG, Roth JA, Nemunaitis J, et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst, 1999, 91:763-771.
  • 3Chada S, Mhashilkar A, Roth JA, et al. Development of vaccines against self-antigens: the p53 paradigm. Curr Opin Drug Discov Devel, 2003, 6:169-173.
  • 4Martin B, Bradly GW. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res,1999, 59: 1391-1399.
  • 5Martin LS, Young RS. p53 regulation of DNA excision repair pathways. Mutagenesis, 2002, 17: 149-156.
  • 6Introgen′s Intrabronchial Advexin therapy demonstrates safety and clinical activity in bronchoalveolar lung cancer. Introgen Therapeutics, Inc. News Release, 2003-06-02.
  • 7Phase 2 breast cancer study shows clinical responses in 90 percent of patients treated with Introgen′s Advexin therapy. Introgen Therapeutics, Inc. News Release, 2003-06-02.
  • 8Buller RE, Runnebaum IB, Karlan BY, et al. A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Cancer Gene Ther. 2002,9:553-566.
  • 9Shimada H, Matsubara H, Ochiai T. p53 gene therapy for esophageal cancer. J Gastroenterol. 2002, 37 Suppl 14:87-91.
  • 10Weill D, Mack M, Roth J, et al. Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection. Chest. 2000,118:966-970.

共引文献36

同被引文献13

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部